193 related articles for article (PubMed ID: 28732145)
41. Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a clinicopathological study of 14 Epstein-Barr virus-positive cases.
Elsayed AA; Satou A; Eladl AE; Kato S; Nakamura S; Asano N
Histopathology; 2017 Mar; 70(4):579-594. PubMed ID: 27735994
[TBL] [Abstract][Full Text] [Related]
42. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
43. Tissue flow cytometry immunophenotyping in the diagnosis and classification of non-Hodgkin's lymphomas: a retrospective evaluation of 1,792 cases.
Demurtas A; Stacchini A; Aliberti S; Chiusa L; Chiarle R; Novero D
Cytometry B Clin Cytom; 2013 Mar; 84(2):82-95. PubMed ID: 23325563
[TBL] [Abstract][Full Text] [Related]
44. The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin lymphoma.
Salama ME; Rajan Mariappan M; Inamdar K; Tripp SR; Perkins SL
Int J Surg Pathol; 2010 Apr; 18(2):121-8. PubMed ID: 19223373
[TBL] [Abstract][Full Text] [Related]
45. A double-positive CD4+CD8+ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma.
Rahemtullah A; Reichard KK; Preffer FI; Harris NL; Hasserjian RP
Am J Clin Pathol; 2006 Nov; 126(5):805-14. PubMed ID: 17050078
[TBL] [Abstract][Full Text] [Related]
46. CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD).
Jacob MC; Favre M; Lemarc'Hadour F; Sotto MF; Bonnefoix T; Sotto JJ; Bensa JC
Am J Hematol; 1992 Jan; 39(1):45-51. PubMed ID: 1531569
[TBL] [Abstract][Full Text] [Related]
47. Novel CD19 expression in a peripheral T cell lymphoma: A flow cytometry case report with morphologic correlation.
Rizzo K; Stetler-Stevenson M; Wilson W; Yuan CM
Cytometry B Clin Cytom; 2009 Mar; 76(2):142-9. PubMed ID: 18671252
[TBL] [Abstract][Full Text] [Related]
48. [Clinicopathologic study of 40 cases of mediastinal tumours of haematopoietic and lymphoid tissues].
Chen DB; Wang Y; Song QJ; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):376-81. PubMed ID: 22932404
[TBL] [Abstract][Full Text] [Related]
49. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
50. A fulminant case of classical Hodgkin lymphoma: A diagnostic dilemma of Epstein-Barr virus-positive large B-cell neoplasms.
Ichimata S; Kobayashi M; Ohya M; Otsuki T; Yanagisawa K; Tateishi K; Kato A; Matsuo A; Kanno H
Pathol Int; 2019 Jul; 69(7):407-413. PubMed ID: 31215109
[TBL] [Abstract][Full Text] [Related]
51. Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas.
Carbone A; Gloghini A; Volpe R
Cancer; 1992 Dec; 70(11):2691-8. PubMed ID: 1330287
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of the reactive T-cell infiltrate in uveitis and intraocular lymphoma with flow cytometry of vitreous fluid (an American Ophthalmological Society thesis).
Davis JL; Ruiz P; Shah M; Mandelcorn ED
Trans Am Ophthalmol Soc; 2012 Dec; 110():117-29. PubMed ID: 23818738
[TBL] [Abstract][Full Text] [Related]
53. T-cell-rich B-cell lymphoma - diagnostic and therapeutic aspects.
Axdorph U; Porwit-Macdonald A; Sjøberg J; Grimfors G; Bjørkholm M
APMIS; 2002 May; 110(5):379-90. PubMed ID: 12076255
[TBL] [Abstract][Full Text] [Related]
54. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma without mediastinal disease: mimicking nodular sclerosis classical Hodgkin lymphoma.
Iwaki N; Sato Y; Kurokawa T; Maeda Y; Ohno K; Takeuchi M; Takata K; Orita Y; Nakao S; Yoshino T
Med Mol Morphol; 2013 Sep; 46(3):172-6. PubMed ID: 23512149
[TBL] [Abstract][Full Text] [Related]
55. Natural killer cell subsets and natural killer-like T-cell populations in benign and neoplastic B-cell proliferations vary based on clinicopathologic features.
Gibson SE; Swerdlow SH; Felgar RE
Hum Pathol; 2011 May; 42(5):679-87. PubMed ID: 21292303
[TBL] [Abstract][Full Text] [Related]
56. The role of flow cytometry in the diagnosis of non- Hodgkin's lymphoma, Hodgkin's lymphoma, granulomatous inflammation and reactive lymph node specimens.
Gunduz E; Celebioglu M; Meltem Akay O; Uskudar Teke H; Sahin Mutlu F; Gulbas Z
J BUON; 2013; 18(3):739-45. PubMed ID: 24065493
[TBL] [Abstract][Full Text] [Related]
57. Survival among patients with composite and sequential lymphoma between primary mediastinal lymphoma/diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A population-based study.
Tao Y; Chen H; Liu D; Dai X
Leuk Res; 2021 Dec; 111():106669. PubMed ID: 34333276
[TBL] [Abstract][Full Text] [Related]
58. Overexpression of CD7 in classical Hodgkin lymphoma-infiltrating T lymphocytes.
Seegmiller AC; Karandikar NJ; Kroft SH; McKenna RW; Xu Y
Cytometry B Clin Cytom; 2009 May; 76(3):169-74. PubMed ID: 18956470
[TBL] [Abstract][Full Text] [Related]
59. Immunoprofile of Hodgkin's lymphoma in India.
Patkar N; Mehta J; Kulkarni B; Pande R; Advani S; Borges A
Indian J Cancer; 2008; 45(2):59-63. PubMed ID: 18626150
[TBL] [Abstract][Full Text] [Related]
60. Morphologic, immunphenotypic and clinical discriminators between T-cell/histiocyte-rich large B-cell lymphoma and lymphocyte-predominant Hodgkin lymphoma.
Mourad WA; Al Thani S; Tbakhi A; Al Omari M; Khafaga Y; Shoukri M; El Weshi A; Al Shabana M; Ezzat A
Hematol Oncol Stem Cell Ther; 2008; 1(1):22-7. PubMed ID: 20063524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
